No Detail Found!

Case series pattern of chemotherapy induced toxicities in children with ewing sarcoma: a case series

Author(s)
Rabiha Manzoor Department of Pediatric Hematology & Oncology, CMH,Rawalpindi-,Pakistan
Shaista Naz Department of Pediatric Hematology & Oncology, CMH,Rawalpindi-,Pakistan
Sobia Ali Department of Community Medicine, Ayub Medical College,Abbottabad-,Pakistan
Rabia Tariq Pakistan Institute of Medical Sciences,Islamabad-,Pakistan
Ifnan Shamraiz Department of Pediatric Hematology & Oncology, CMH,Rawalpindi-,Pakistan
Abdul Wahab Siddique Department of Pediatric Hematology & Oncology, CMH,Rawalpindi-,Pakistan
Abstract
Background: Ewing sarcoma is a rare and aggressive bone or soft tissue cancer that primarily affects children and adolescents. Estimated incidence of Ewing sarcoma is reported to be 1.2-2.9 in one million individuals in England and 1 in one million in the US. Objective of the study was to determine the pattern, and influence of gender and age on chemotherapy-induced toxicities in children with Ewing sarcoma. This descriptive case series was carried out at the Department of Paediatric Oncology, CMH Rawalpindi, from January 2014 to June 2023. Methods: Children of either gender aged less than 18 years and diagnosed cases of Ewing Sarcoma were enrolled. All patients were given VIDE (vincristine, ifosamide, doxorubicin, etoposide) chemotherapy and patients were observed for chemotherapy induced toxicities. Chi square test was used to analyze significance of age and gender on toxicity. Results: In a total of 59 children 35 (59.3%) were male and 24 (40.7%) females. Out of these 11 children expired. The mean age was 7.59±3.87 years. Younger age was strongly associated with higher occurrence of toxicity specifically children under 5 years being most affected (p<0.05). Neutropenia, nausea and vomiting, thrombocytopenia, and diarrhoea were the most frequent adverse events observed in 53 (89.9%), 37 (62.7%), 36 (61.0%), and 36 (61.0%) patients respectively. There was no association of gender with chemotherapy induced toxicity. Neutropenic sepsis and diarrhoea were positively associated with mortality in the 11 children who expired (p<0.05). Conclusion: Neutropenia, nausea and vomiting, mucositis, thrombocytopenia and diarrhoea were the most frequent chemotherapy induced toxicities in children with Ewing sarcoma. Younger children specifically under 5 years have a higher chance of chemotherapy induced toxicities however gender did not seem to influence related toxicities. Neutropenic sepsis was the major predictor of mortality warranting higher vigilance and aggressive management of infections.
Publication Details
Page(s) 816-820
Published Journal: Journal of Ayub Medical College, Volume: 36, Issue: 4, Year: 2024

Request the full text from PASTIC

Keywords
Adverse effects, chemotherapy, Ewing sarcoma, Antineoplastic Combined Chemotherapy Protocols, Neutropenia
References
Whelan J,McTiernan A,Cooper N,Wong YK,Francis M,Vernon S .2012 .Incidence and survival of malignant bone sarcomas in England 1979-2007. Int J Cancer, 131(4) : E508-17.
Khan S,Abid Z,Haider G,Bukhari N,Zehra D,Hashmi M .2021 .Incidence of Ewing's Sarcoma in Different Age Groups, Their Associated Features, and Its Correlation with Primary Care Interval. Cureus, 13(3) : e13986.
Kaçmaz İE,Keçeci B,Basa CD,Sabah D. .2020 .Treatment of pelvic Ewing's sarcoma: Pros and cons of chemotherapy plus definitive radiotherapy versus surgery. Acta Orthop Traumatol Turc, 54(1) : 42-8.
Zöllner SK,Amatruda JF,Bauer S,Collaud S,de Alava E,DuBois SG,Sarcoma-Diagnosis Clinical,Challenges Future,Perspectives Future .2021 .. J Clin Med, 10(8) : 1685.
Indelicato DJ,Keole SR,Shahlaee AH,Shi W,Morris CG,Marcus RB .2008 .Definitive radiotherapy for ewing tumors of extremities and pelvis: long-term disease control, limb function, and treatment toxicity. Int J Radiat Oncol Biol Phys, 72(3) : 871-7.
Sanguanboonyaphong P,Komvilaisak P,Suwannaying K,Yoodee J,Saeteaw M,Chanthawong S .2022 .Predictors of Chemotherapy Induced Adverse Events in Pediatric Osteosarcoma Patients. Asian Pac J Cancer Prev, 23(1) : 93-100.
Anderton J,Moroz V,Marec-Bérard P,Gaspar N,Laurence V,Martin-Broto J .2020 .International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours -. EWING 2012 Protocol. Trials, 21(1) : 96.
Ladenstein R,Pötschger U,Le Deley MC,Whelan J,Paulussen M,Oberlin O .2010 .Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. J Clin Oncol, 28(20) : 3284-91.
Le Deley MC,Paulussen M,Lewis I,Brennan B,Ranft A,Whelan J .2014 .Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial. J Clin Oncol, 32(23) : 2440-8.
Weber DC,Beer J,Kliebsch UL,Teske C,Baust K,Walser M .2022 .Quality-of-life evaluations in children and adolescents with Ewing sarcoma treated with pencil-beam-scanning proton therapy. Pediatr Blood Cancer, 69(12) : e29956.
Davis L,Malempati S. .2014 .Ewing sarcoma in adolescents and young adults: diagnosis and treatment. Clin Oncol Adolesc Young Adults, 4 : 21-31.
Umeda K,Miyamura T,Yamada K,Sano H,Hosono A,Sumi M .2021 .4(3):e1329.. Cancer Rep (Hoboken), : .
Werier J,Yao X,Caudrelier JM,Di Primio G,Ghert M,Gupta AA .2016 .A systematic review of optimal treatment strategies for localized Ewing's sarcoma of bone after neoadjuvantchemotherapy. Surg Oncol, 25(1) : 16-23.
Paioli A,Luksch R,Faioli F,Tamburini A,Cesari M,Palmerini E .2014 .Chemotherapy-related toxicity in patients with non-metastatic Ewing sarcoma: influence of sex and age. J Chemother, 26(1) : 49-56.
Juergens C,Weston C,Lewis I,Whelan J,Paulussen M,Oberlin O,W.I.N.G. O .2006 .99 clinical trial. Pediatr Blood Cancer, 47(1) : 22-9.
Basu SK,Fernandez ID,Fisher SG,Asselin BL,Lyman GH .2005 .Length of stay and mortality associated with febrile neutropenia among children with cancer. J Clin Oncol, 23(31) : 7958-66.
Mhaissen MN,Rodriguez A,Gu Z,Zhu H,Tang L,Sun Y .2017 .Epidemiology of Diarrhoeal Illness in Pediatric Oncology Patients. J Pediatric Infect Dis Soc, 6(3) : 275-80.
Hartman RM,Cohen AL,Antoni S,Mwenda J,Weldegebriel G,Biey J .2023 .Risk factors for mortality among children younger than age 5 years with severe diarrhoea in low- and middle-income countries: Findings from the World Health Organization-coordinated global rotavirus and pediatric diarrhoea surveillance networks. Clin Infect Dis, 76(3) : e1047-53.
.2024 .. 2024 Accepted: November, 11 : .
0

Citations

0

Downloads

52

Views